NorthWest Biotherapeutics Inc (NWBO)

[Doktornolittle]

Duke-Polio: It is only an open label, single leg, phase 1, and it does not complete for 8 to 20 months, depending on what you call complete.

Stated otherwise... this is not news, but for some reason it is getting a lot of attention on the eve of expected news about NWBO and it's GBM trial.

Not responding to your question... that is for others.


https://clinicaltrials.gov/ct2/show/NCT01491893?term=polio+gbm&rank=1

Condition Intervention Phase
GBM
Glioblastoma
Glioma
Malignant Glioma
Biological: PVSRIPO
Phase 1

Study Type: Interventional
Study Design: Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Dose-finding and Safety Study of an Oncolytic Polio/Rhinovirus Recombinant Against Recurrent WHO Grade IV Malignant Glioma

Estimated Enrollment: 65
Study Start Date: January 2012
Estimated Study Completion Date: January 2018
Estimated Primary Completion Date: January 2017 (Final data collection date for primary outcome measure)